DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34 + CD15 − cells in early chronic-phase chronic myeloid leukemia - Role of intra-Clonal HEterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias Accéder directement au contenu
Article Dans Une Revue Molecular Oncology Année : 2018

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34 + CD15 − cells in early chronic-phase chronic myeloid leukemia

Résumé

Despite the high efficiency of tyrosine kinase inhibitors (TKI), some patients with chronic myeloid leukemia (CML) will display residual disease that can become resistant to treatment, indicating intraclonal heterogeneity in chronic-phase CML (CP-CML). To determine the basis of this heterogene-ity, we conducted the first exhaustive characterization of the DNA methyla-tion pattern of sorted CP-CML CD34 + CD15 À (immature) and CD34 À CD15 + (mature) cells at diagnosis (prior to any treatment) and compared it to that of CD34 + CD15 À and CD34 À CD15 + cells isolated from healthy donors (HD). In both cell types, we identified several hundreds of differentially methylated regions (DMRs) showing DNA methylation changes between CP-CML and HD samples, with only a subset of them in common between CD34 + CD15 À and CD34 À CD15 + cells. This suggested DNA methylation variability within the same CML clone. We also identified 70 genes that could be aberrantly repressed upon hypermethylation and 171 genes that could be aberrantly expressed upon hypomethylation of some of these DMRs in CP-CML cells, among which 18 and 81, respectively, were in CP-CML CD34 + CD15 À cells only. We then validated the DNA methylation and expression defects of selected candidate genes. Specifically, we identified GAS2, a candidate oncogene, as a new example of gene the hypomethylation of which is associated with robust overexpression in CP-CML cells. Altogether, we demonstrated that DNA methylation abnormalities exist at early stages of CML and can affect the transcriptional landscape
Fichier principal
Vignette du fichier
Molecular_Oncology 2018.pdf (1.26 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01917284 , version 1 (09-11-2018)

Identifiants

Citer

Stéphanie Maupetit-Méhouas, Franck Court, Céline Bourgne, Agnès Guerci-Bresler, Pascale Cony-Makhoul, et al.. DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34 + CD15 − cells in early chronic-phase chronic myeloid leukemia. Molecular Oncology, 2018, 12 (6), pp.814 - 829. ⟨10.1002/1878-0261.12191⟩. ⟨hal-01917284⟩
219 Consultations
262 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More